Screening of candidate tumor-suppressor genes in 3p21.3 and investigation of the methylation of gene promoters in oral squamous cell carcinoma

Oncology Reports

Volumn 29, Issue 3, 2013, Pages 1175-1182

  Wang, Kai ^a   Ling, Tianyou ^a   Wu, Hanjiang ^a   Zhang, Jie ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

3p21.3; Gene expression; Gene promoter; Hypermethylation; Oral squamous cell carcinoma

Indexed keywords

AZACITIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AXUD1 GENE; CARCINOGENESIS; CELL STRAIN; CELL STRAIN TCA8113; CHROMOSOME 3P; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENETIC SCREENING; GNAT1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMA3B GENE; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; PROMOTER REGIONS, GENETIC; SEMAPHORINS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME; YOUNG ADULT;

EID: 84872787919     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2213     Document Type: Article

References (53)

1. Massano J, Regateiro FS, Januario G and Ferreira A: Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102: 67-76, 2006. (Pubitemid 44016111)
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
3. Lippman SM and Hong WK: Molecular markers of the risk of oral cancer. N Engl J Med 344: 1323-1326, 2001. (Pubitemid 32372968)
4. Vokes EE, Weichselbaum RR, Lippman SM and Hong WK: Head and neck cancer. N Engl J Med 328: 184-194, 1993.
5. Zhou W, Feng X, Li H, et al: Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Acta Biochim Biophys Sin 41: 54-62, 2009.
6. Friend SH, Bernards R, Rogelj S, et al: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646, 1986. (Pubitemid 16008560)
7. Chiba I, Shindoh M, Yasuda M, et al: Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 12: 1663-1668, 1996. (Pubitemid 26146290)
8. Call KM, Glaser T, Ito CY, et al: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520, 1990.
9. Kamb A, Shattuck-Eidens D, Eeles R, et al: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8: 23-26, 1994.
10. Aoki K and Taketo MM: Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci 120: 3327-3335, 2007. (Pubitemid 350028340)
11. Hahn SA, Schutte M, Hoque AT, et al: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353, 1996.
12. Ohta M, Inoue H, Cotticelli MG, et al: The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597, 1996. (Pubitemid 26071739)
13. Li J, Yen C, Liaw D, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997. (Pubitemid 27148818)
14. Steck PA, Pershouse MA, Jasser SA, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997. (Pubitemid 27147102)
15. Imai FL, Uzawa K, Miyakawa A, Shiiba M and Tanzawa H: A detailed deletion map of chromosome 20 in human oral squamous cell carcinoma. Int J Mol Med 7: 43-47, 2001.
16. Miyakawa A, Wang XL, Nakanishi H, et al: Allelic loss on chromosome 22 in oral cancer: Possibility of the existence of a tumor suppressor gene on 22q13. Int J Oncol 13: 705-709, 1998. (Pubitemid 28435346)
17. Sparano A, Quesnelle KM, Kumar MS, et al: Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 116: 735-741, 2006. (Pubitemid 44318029)
18. Yamamoto N, Mizoe J, Numasawa H, Tsujii H, Shibahara T and Noma H: Allelic loss on chromosomes 2q, 3p and 21q: possibly a poor prognostic factor in oral squamous cell carcinoma. Oral Oncol 39: 796-805, 2003. (Pubitemid 38373464)
19. Roz L, Wu CL, Porter S, et al: Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res 56: 1228-1231, 1996. (Pubitemid 26080959)
20. Yamamoto N, Kuroiwa T, Katakura A, Shibahara T and Choudhury C: Loss of heterozygosity (LOH) on chromosomes 2q, 3p and 21q in Indian oral squamous cell carcinoma. Bull Tokyo Dent Coll 48: 109-117, 2007.
21. van den Berg A, Dijkhuizen T, Draaijers TG, et al: Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development. Genes Chromosomes Cancer 19: 228-232, 1997. (Pubitemid 27330233)
22. Hung J, Kishimoto Y, Sugio K, et al: Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273: 1908, 1995.
23. Zhu Y, Spitz MR, Zheng YL, Hong WK and Wu X: BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk. Cancer 95: 563-568, 2002. (Pubitemid 34810181)
24. Senchenko V, Liu J, Braga E, et al: Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene 22: 2984-2992, 2003. (Pubitemid 36648926)
25. Senchenko VN, Liu J, Loginov W, et al: Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 23: 5719-5728, 2004. (Pubitemid 39093017)
26. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K and Herman JG: Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10: 687-692, 2001. (Pubitemid 32331576)
27. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21, 2002. (Pubitemid 34049633)
28. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 321: 209-213, 1986. (Pubitemid 16016411)
29. Merlo A, Herman JG, Mao L, et al: 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692, 1995.
30. Steinmann K, Sandner A, Schagdarsurengin U and Dammann RH: Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol Rep 22: 1519-1526, 2009.
31. Zhang H, Feng X, Liu W, et al: Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines. J Cell Biochem 112: 1832-1843, 2011.
32. Zhou W, Feng X, Li H, et al: Functional evidence for a nasopha-ryngeal carcinoma-related gene BCAT1 located at 12p12. Oncol Res 16: 405-413, 2007.
33. Peng D, Ren CP, Yi HM, et al: Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin 38: 349-355, 2006.
34. Zhou L, Feng X, Shan W, et al: Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma. Oncology 72: 357-363, 2007. (Pubitemid 351238150)
35. Tuhkanen H, Anttila M, Kosma VM, et al: Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int J Cancer 109: 247-252, 2004. (Pubitemid 38240927)
36. Liao YC and Lo SH: Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver. Int J Biochem Cell Biol 40: 843-847, 2008. (Pubitemid 351329658)
37. Kang JU, Koo SH, Kwon KC and Park JW: Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung. Int J Oncol 37: 327-335, 2010.
38. Ishiguro H, Tsunoda T, Tanaka T, Fujii Y, Nakamura Y and Furukawa Y: Identification of AXUD1, a novel human gene induced by AXIN1 and its reduced expression in human carcinomas of the lung, liver, colon and kidney. Oncogene 20: 5062-5066, 2001. (Pubitemid 32769797)
39. Glavic A, Molnar C, Cotoras D and de Celis JF: Drosophila Axud1 is involved in the control of proliferation and displays pro-apoptotic activity. Mech Dev 126: 184-197, 2009.
40. Ngo JT, Bateman JB, Klisak I, Mohandas T, Van Dop C and Sparkes RS: Regional mapping of a human rod alpha-transducin (GNAT1) gene to chromosome 3p22. Genomics 18: 724-725, 1993. (Pubitemid 24021100)
41. Yi HM, Ren CP, Peng D, Zhou L, Li H and Yao KT: Expression, loss of heterozygosity, and methylation of GNAT1 gene in naso-pharyngeal carcinoma. Ai Zheng 26: 9-14, 2007 (In Chinese).
42. Tomizawa Y, Sekido Y, Kondo M, et al: Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA 98: 13954-13959, 2001. (Pubitemid 33116005)
43. Tse C, Xiang RH, Bracht T and Naylor SL: Human semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res 62: 542-546, 2002. (Pubitemid 34106429)
44. Ochi K, Mori T, Toyama Y, Nakamura Y and Arakawa H: Identification of semaphorin3B as a direct target of p53. Neoplasia 4: 82-87, 2002. (Pubitemid 34075893)
45. Sekido Y, Bader S, Latif F, et al: Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA 93: 4120-4125, 1996. (Pubitemid 26146727)
46. Lerman MI and Minna JD: The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 60: 6116-6133, 2000.
47. Li W, Li X, Wang W, et al: NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma. Carcinogenesis 32: 1305-1314, 2011.
48. Mao WM, Li P, Zheng QQ, et al: Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer. Arch Med Res 42: 182-188, 2011.
49. Liu WB, Ao L, Zhou ZY, et al: CpG island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine. Biochem Biophys Res Commun 402: 507-514, 2010.
50. An JH, Choi A, Shin KJ, Yang WI and Lee HY: DNA methylation-specific multiplex assays for body fluid identification. Int J Legal Med 402: 507-514, 2012.
51. Riquelme E, Tang M, Baez S, et al: Frequent epigenetic inacti-vation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma. Cancer Lett 250: 100-106, 2007. (Pubitemid 46483848)
52. Kuroki T, Trapasso F, Yendamuri S, et al: Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res 63: 3352-3355, 2003. (Pubitemid 36735894)
53. Ito M, Ito G, Kondo M, et al: Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. Cancer Lett 225: 131-139, 2005. (Pubitemid 40732776)